Company Filing History:
Years Active: 2011
Title: Inventor Spotlight: Alan Neubert
Introduction
Alan Neubert is an innovative inventor based in North Attleborough, Massachusetts, known for his significant contribution to the field of organic compounds. He holds one patent that addresses critical issues related to enzyme activity and conditions mediated by protein tyrosine phosphatases (PTPases).
Latest Patents
His patent focuses on organic compounds formulated as inhibitors of protein tyrosine phosphatases. These compounds have potential applications in treating various conditions associated with PTPase activity, such as insulin resistance linked to obesity, glucose intolerance, diabetes mellitus, and hypertension. Furthermore, the compounds could be beneficial in preventing and treating cancer, osteoporosis, musculoskeletal diseases, neurodegenerative diseases, and inflammation-related disorders.
Career Highlights
Alan Neubert is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to push the boundaries of pharmaceutical research, particularly in the realm of metabolic diseases and oncology.
Collaborations
Throughout his career, Alan has collaborated with notable colleagues, including David Weninger Barnes and Young-shin Kwak. These partnerships have been invaluable in advancing research initiatives and translating innovative ideas into practical solutions.
Conclusion
Alan Neubert's contributions to the field of organic compounds illustrate the profound impact that a dedicated inventor can have in healthcare. His pioneering work at Novartis AG, along with collaborative efforts, continues to pave the way for new treatments that address serious health challenges.